ICD-10 Coding for Laryngeal Mass(C32.0, C32.1, J38.7)
Complete ICD-10-CM coding and documentation guide for Laryngeal Mass. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Laryngeal Mass
C32.0-C32.9Primary Range
Malignant neoplasms of the larynx
This range includes specific codes for malignant neoplasms of different parts of the larynx, crucial for accurate diagnosis and treatment planning.
Other diseases of the larynx
This code is used for non-neoplastic conditions affecting the larynx, such as laryngeal edema or granuloma.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C32.0 | Malignant neoplasm of glottis | Use when the neoplasm is confirmed to be in the glottis through biopsy or imaging. |
|
| C32.1 | Malignant neoplasm of supraglottis | Use when the neoplasm is confirmed to be in the supraglottic region through biopsy or imaging. |
|
| J38.7 | Other diseases of larynx | Use for non-neoplastic conditions affecting the larynx, such as granulomas or laryngoceles. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for laryngeal mass
Essential facts and insights about Laryngeal Mass
Primary ICD-10-CM Codes for laryngeal mass
Decision Criteria
clinical Criteria
- Confirmed presence of a malignant neoplasm in the glottis
documentation Criteria
- Detailed biopsy report confirming squamous cell carcinoma
Applicable To
- Squamous cell carcinoma of true vocal cord
Excludes
- Benign neoplasms of the larynx
Clinical Validation Requirements
- Biopsy-proven squamous cell carcinoma
- Imaging showing lesion in glottis
Code-Specific Risks
- Risk of using unspecified codes if exact site is not documented
Coding Notes
- Ensure documentation specifies the exact location within the larynx to avoid unspecified coding.
C32.1 - Malignant neoplasm of supraglottis
Use when the neoplasm is confirmed to be in the supraglottic region through biopsy or imaging.
Applicable To
- Squamous cell carcinoma of laryngeal epiglottis
Excludes
- Benign neoplasms of the larynx
Clinical Validation Requirements
- Biopsy-proven squamous cell carcinoma
- Imaging showing lesion in supraglottis
Coding Notes
Ensure documentation specifies the exact location within the larynx to avoid unspecified coding.
J38.7 - Other diseases of larynx
Use for non-neoplastic conditions affecting the larynx, such as granulomas or laryngoceles.
Applicable To
- Laryngeal granuloma
- Laryngocele
Excludes
- Malignant neoplasms of the larynx
Clinical Validation Requirements
- Clinical diagnosis of non-neoplastic laryngeal condition
Coding Notes
Ensure differentiation between neoplastic and non-neoplastic conditions.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Dysphonia
R49.0Differential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Laryngeal Mass to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C32.0.
Impact
Clinical: May lead to inappropriate treatment planning., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims due to incomplete documentation.
Mitigation Strategy
Always document laterality when applicable, Use templates that prompt for laterality
Impact
Reimbursement: May lead to reduced reimbursement due to lack of specificity., Compliance: Increases risk of audit and non-compliance with coding guidelines., Data Quality: Affects data quality and accuracy in clinical records.
Mitigation Strategy
Ensure documentation specifies the exact location within the larynx to use specific codes.
Impact
High risk of audit if unspecified codes are used when specific site is documented.
Mitigation Strategy
Ensure documentation includes specific site and histology to use the most accurate code.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Laryngeal Mass, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Laryngeal Mass
Use these documentation templates to ensure complete and accurate documentation for Laryngeal Mass. These templates include all required elements for proper coding and billing.
Biopsy-confirmed laryngeal cancer
Specialty: OncologyRequired Elements
- Anatomic site
- Histologic type
- Tumor size
- Laterality
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Laryngeal Mass? Ask your questions below.